Abstract:e22544 Background: Cancer is a leading cause of mortality and has been associated with an increasing prevalence of psychological disorders. Previous studies indicate that approximately 1 in 8 individuals diagnosed with lung cancer also experience symptoms of depression. Our study aimed to assess the disparities in the prevalence and association of Anxiety and Major depressive disorder (MDD) in lung cancer patients. Methods: Using the National Inpatient Sample 2017-2020, we identified lung cancer patients with regional and advanced metastatic disease. They were divided into two groups - with and without concomitant Anxiety and MDD. Baseline demographic characteristics were analyzed to assess disparities in prevalence, and multivariate logistic regression was used to evaluate the association of Anxiety and MDD in these patients. Results: A total of 461975 patients had lung cancer, and 25780(5%) had concurrent diagnoses of Anxiety and MDD. The anxiety + MDD group had 70% females and 30% males (p < 0.001).Females had an increased likelihood of MDD + Anxiety (OR = 2.36 (2.21-2.52); p 65: OR = 0.45(0.25-0.81); p = 0.008). Compared to the white population, patients of other races had a decreased likelihood of MDD + Anxiety (Black: OR = 0.41( 0.36-0.47), p < 0.001; Hispanic: OR = 0.65( 0.55-0.77), p < 0.001; Other races OR = 0.60(0.48-0.76), p < 0.001). Private insurance and patients without insurance were less likely to have MDD + Anxiety (OR = 0.74(0.67-0.81) and OR = 0.56(0.44-0.71), p < 0.001, respectively). Patients admitted to teaching and large hospitals had an increased likelihood of MDD + Anxiety compared to smaller and nonteaching hospitals (OR = 1.13(1.03-1.24), p = 0.006 and OR = 1.14(1.03-1.25), p = 0.007, respectively). Patients with Hyperlipidemia, Hypertension, COPD, and Obesity were more likely to have MDD + Anxiety (OR = 1.39(1.30-1.48), p < 0.001; OR = 1.11(1.03-1.18), p = 0.002; OR = 1.29(1.21-1.38), p < 0.001 and OR = 1.33(1.22-1.45), p < 0.001 respectively). In contrast, patients with Diabetes had a decreased likelihood of concomitant Anxiety + Depression (OR = 0.92(0.85-0.99), p = 0.04). Lung cancer patients with concurrent Anxiety + MDD had a higher total cost of hospitalization. (+$ 2611(66-5156); p = 0.04). Conclusions: Female lung cancer patients and white individuals had an increased risk of anxiety and depression. Patients with private insurance had decreased risk, and those admitted to larger and teaching hospitals had increased association with these psychological disorders. Devising comprehensive strategies to effectively control underlying psychiatric conditions is crucial for improving outcomes in lung cancer patients, aiming to enhance quality of life and prolong life expectancy.

Frequency of Depression and Anxiety in Patients With Lung Cancer Undergoing Chemotherapy: A Single-Center, Cross-Sectional Study From Vietnam

Depression and Anxiety as Key Factors Associated With Quality of Life Among Lung Cancer Patients in Hai Phong, Vietnam

Depression Symptoms among Patients with Lung Cancer and their Relations with Demographic Characteristics

Quality of Life and Psychological Distress of Lung Cancer Patients Undergoing Chemotherapy

Identifying symptom cluster in cancer patients undergoing chemotherapy-in Vietnam: A cross-sectional study

Disparities in the prevalence of anxiety and major depressive disorder in patients with lung cancer and the associated risk factors: A retrospective analysis.

Depression in Patients With Lung Cancer: Prevalence and Risk Factors Derived From Quality-of-Life Data

Chemotherapeutic Response and Prognosis among Lung Cancer Patients with and without Depression

Depression and Anxiety in Patients With Cancer: A Cross-Sectional Study

Prevalence and risk factors of depression and anxiety for inpatients with lung cancer in China: A hospital-based cross-sectional study

Effect of Nursing Method of Psychological Intervention Combined with Health Education on Lung Cancer Patients Undergoing Chemotherapy

Prevalence and risk factors for anxiety in patients with early- and middle-stage lung cancer: a cross-sectional study

Association Between Depression and Anxiety Status of Breast Cancer Patients Undergoing Adjuvant Chemotherapy and Chemotherapy-induced Adverse Events.

Proportion and related factors of depression and anxiety for inpatients with lung cancer in China: a hospital-based cross-sectional study

Morbidity and associated factors of depressive disorder in patients with lung cancer

Depression and its impact on health-related quality of life among Chinese inpatients with lung cancer

Psychological symptoms and quality of life in Chinese early-stage breast cancer patients throughout chemotherapy.

Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety

Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy?